Budget Impact of the 14-Gene Risk-Score (RS) Assay to Inform Adjuvant Chemotherapy Decisions in Early-Stage Non-Small Cell Lung Cancer (NSCLC)

Authors :: J.J. Carlson
Paul Billings
Scott D. Ramsey
Robert H. Dumanois
Joshua A. Roth
Source :: Value in Health. 17:A74
Publication Year :: 2014
Publisher :: Elsevier BV, 2014.

Subjects :: Oncology
medicine.medical_specialty
Framingham Risk Score
business.industry
Adjuvant chemotherapy
Health Policy
Public Health, Environmental and Occupational Health
non-small cell lung cancer (NSCLC)
Budget impact
medicine.disease
Internal medicine
Medicine
Stage (cooking)
business
Gene

Full Text Access

Tools